Previous Close | 61.05 |
1-Year Change | -0.05% |
6-Months Change | -10.43% |
3-Months Change | 2.8% |
Moving Avg (50d) | 61.192 |
Moving Avg (200d) | 61.23 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 1.18B |
Beta (3-Years) | 0.82 |
Revenue Growth (ttm) | 34.27% |
Net Profit Margin (ttm) | 5.01% |
Return On Assets (ttm) | 2.93% |
EPS (ttm) | 1.15 |
PE Ratio (ttm) | 53.09 |
Dividend Yield | 0.13% |
Asset Description: | ANI Pharmaceuticals, Inc. |
Predicted Direction: | Buy |
Signal Strength: | Neutral |
Forecast Date: | 2024-09-12 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
59.829 | 57.997 | 56.776 | 54.945 | 51.892 | 48.84 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.